1996
DOI: 10.1016/s0140-6736(96)91417-8
|View full text |Cite
|
Sign up to set email alerts
|

Effect of smoking cessation on cervical lesion size

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
45
2
4

Year Published

1997
1997
2016
2016

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 117 publications
(55 citation statements)
references
References 17 publications
4
45
2
4
Order By: Relevance
“…The fact that the significant excess risk for CIN 2-3 associated with smoking was not reduced by adjustment for HPV indicates that smoking does indeed have a causal association with CIN 2-3. This is also supported by reports indicating that smoking cessation facilitates regression of CIN (Szarewski et al, 1996). Whether smoking is an entirely independent risk factor or works as a risk modifier of HPV exposure could not be disclosed in the present study.…”
Section: Discussionsupporting
confidence: 83%
“…The fact that the significant excess risk for CIN 2-3 associated with smoking was not reduced by adjustment for HPV indicates that smoking does indeed have a causal association with CIN 2-3. This is also supported by reports indicating that smoking cessation facilitates regression of CIN (Szarewski et al, 1996). Whether smoking is an entirely independent risk factor or works as a risk modifier of HPV exposure could not be disclosed in the present study.…”
Section: Discussionsupporting
confidence: 83%
“…However, infection with HR HPV does not invariably lead to the development of high grade cervical lesions and there is a clear requirement for other cofactors, presumably to advance the oncogenic process initiated by HR HPV (zur Hausen, 1999). The effects of co-factors are difficult to measure objectively because of the dominant effects of HR HPV infection but tobacco smoking has consistently been associated with cervical cancer (Szarewski et al, 1996) and has been found recently to induce genomic instability in head and neck cancers (Schantz et al, 2000). Other potential co-factors include oral contraceptive use and other sexually transmitted diseases.…”
mentioning
confidence: 99%
“…Individuals were selected into the study on the basis of the exposure (whether or not they had had HPV screening), not the outcome, and as such a case control design would not have been appropriate. Therefore, potential confounders such as age, smoking status, parity and contraceptive use were recorded (smoking and parity increase the risk of CIN progression 18,19 ). These data were divided into categories for ease of analysis: age into 30 years or less, 31-40, 41-50 and 51 years or more; contraceptive into none, oestrogen and progesterone excess (postmenopausal, use of Depoprovera, Implanon and the Mirena Coil); parity as none, one and more than two.…”
Section: Materials and Methods;mentioning
confidence: 99%